Albuterol is NOT Contraindicated After Chlorine Exposure
Albuterol treatment should be administered to patients with dyspnea and expiratory wheezing following chlorine inhalation, as it is the standard bronchodilator therapy for acute bronchospasm regardless of etiology. There are no absolute contraindications to albuterol in this clinical scenario 1.
Rationale for Use
Chlorine gas exposure causes direct chemical injury to the respiratory tract, resulting in:
- Airway inflammation and edema
- Bronchospasm and bronchoconstriction
- Mucous plugging
- Potential non-cardiogenic pulmonary edema
The bronchospasm component responds to β2-agonist therapy. Short-acting β-agonists like albuterol provide rapid, dose-dependent bronchodilation with minimal side effects 2. The mechanism—relaxation of bronchial smooth muscle—is effective regardless of whether the trigger is asthma, COPD, or chemical irritant exposure.
Treatment Approach
For acute bronchospasm with wheezing after chlorine exposure:
Initial therapy:
- Oxygen to maintain SaO2 ≥90%
- Nebulized albuterol 2.5-5 mg every 20 minutes for 3 doses 3
- Consider adding ipratropium bromide 0.5 mg to albuterol for severe cases 4
Dosing specifics:
- Standard dose: 2.5-5 mg via nebulizer every 20 minutes for initial 3 doses
- Can continue every 1-4 hours as needed based on response 3
- Continuous nebulization (10-15 mg/hour) may be considered for severe, refractory bronchospasm 2
Adjunctive therapy for chemical inhalation:
- Systemic corticosteroids (methylprednisolone 125 mg IV) to address airway inflammation 5
- Ipratropium bromide combined with albuterol provides modest additional benefit 2
Important Caveats
Paradoxical bronchospasm: While extremely rare (occurring in <1% of patients), albuterol can paradoxically worsen bronchospasm 1, 6. If wheezing worsens immediately after albuterol administration:
- Stop albuterol immediately
- Provide high-flow oxygen (15 L/min via non-rebreather) 6
- Consider alternative bronchodilators (ipratropium alone)
- Administer systemic corticosteroids
Monitor for:
- Tachycardia and hypertension (common, usually not clinically significant) 1
- Worsening hypoxemia initially (due to V/Q mismatch from bronchodilation—this is expected and not a reason to stop therapy) 2
- Tremor, nervousness (20% incidence, benign) 1
Chemical exposure considerations: Unlike typical asthma, chlorine-induced bronchospasm may be accompanied by significant airway edema and inflammation. If bronchospasm persists despite aggressive albuterol therapy, the issue is likely inflammatory/edematous rather than purely bronchospastic—escalate to corticosteroids and consider racemic epinephrine for laryngeal edema 5.
The only true contraindication to albuterol is documented hypersensitivity to the medication or its components 1. Chlorine exposure with bronchospasm is a clear indication for β2-agonist therapy, not a contraindication.